Typo Errors, Colour Mismatch Lead to Bust of Fake Mounjaro in Gurugram

Written By :  sheeba farhat
Published On 2026-04-24 05:15 GMT   |   Update On 2026-04-24 05:15 GMT
Advertisement

Gurugram: Colour dissimilarity to typographical errors, conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs Control Office to crack down on the illicit sale and production of the blockbuster diabetes and weight loss drug running out of a flat in Gurugram, officials said.

The alleged mastermind Avi Sharma procured raw materials from China through popular e-commerce website Alibaba, said drugs control officer Amandeep Chauhan.

Officials carried out a raid on April 18 and seized fake Mounjaro (tirzepatide) injections worth ₹70 lakh from a vehicle in DLF Phase 4.Giving details of the investigation, Chauhan said the team compared the spurious sample against the original one and found that the boxes of the fake injection had different shades of blue and red.

He also said that there were glaring typographical errors on the fake versions, compared to the original one.

"While both boxes have an illustration of an injection pen, it is clear and bright on the original one, but blurred, dark, and shorter on the fake version," Chauhan said, while adding that they are still waiting for the lab results of the seized samples.

During a follow-up probe, the team raided a flat in Gurugram's Sector 62 where injections were allegedly prepared by mixing water with raw drugs.Police first arrested Mujjamil, a deliveryman from DLF Phase 4. Later, Avi Sharma was also taken into custody.

An official said 32-year-old Sharma started the production of counterfeit injections to earn more money as he wasn't generating much revenue from his previous venture.

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News